Synthetic control arms

A top 20 pharma company was designing a clinical trial for a new rare disease drug. Its goal was to accelerate treatments going to market and increase efficiency in clinical trial design. The company needed a comparator to present to the FDA.

Discover how the pharma company was able to:

License interoperable real-world data
Incorporate patient data into the clinical trial analysis plan
Build out a real-world control group to demonstrate the safety and efficacy to the FDA